The Senate confirmation hearing for Robert F. Kennedy Jr. as HHS Secretary exposed an uncomfortable truth: many of our elected officials appear more committed to protecting the status quo than addressing America’s deepening health crisis, particularly in Black communities.

Throughout the hearing, senators repeatedly attacked Kennedy for citing government studies that challenged conventional narratives. When Kennedy pointed out that 66% of American children now suffer from chronic conditions – up from just 2% during his uncle’s presidency – the response wasn’t concern about this alarming increase but criticism of his proposed solutions.

During his Senate confirmation hearing for HHS Secretary, Robert F. Kennedy Jr. exposed a troubling reality about America’s dependence on pharmaceutical drugs. Despite representing only 4.2% of the world’s population, the United States consumes half of all pharmaceutical drugs globally and generates 70% of pharmaceutical industry profits. This stark disparity emerged during a discussion about youth medication, triggered by Senator Blackburn’s revelation that Tennessee alone spent $90 million on ADHD medications for 417,000 children in a single year. Kennedy highlighted how 15% of American youth are prescribed Aderall or other ADHD medications, with even higher percentages on SSRIs and benzos. Most alarming was his citation of research showing pharmaceutical drugs as the third leading cause of death in America, after heart attacks and cancers.

This over-medication trend, affecting both children and adults, exemplifies a healthcare system that prioritizes drug-based interventions over addressing root causes of health issues. The fact that Americans consume such a disproportionate share of global pharmaceuticals while experiencing worse health outcomes than other developed nations raises serious questions about our approach to healthcare. This testimony challenged the prevailing narrative that more medication equals better health, suggesting instead that America’s pharmaceutical dependency might be contributing to, rather than solving, our national health crisis.

Most telling was Senator Warren’s aggressive defense of pharmaceutical companies during the hearing. While claiming to be tough on Big Pharma, she demanded Kennedy commit to never taking compensation from lawsuits against drug companies for four years after leaving office, even though such litigation could address corporate wrongdoing. The exchange revealed a startling priority: protecting pharmaceutical companies from legal accountability rather than addressing how these companies profit from chronic illness rather than prevention.

When Kennedy refused to rule out holding pharmaceutical companies accountable through litigation, stating, “I’m not going to agree to not sue drug companies,” Warren suggested he was positioning himself to “kill off access to vaccines and make millions of dollars.” This remarkable moment showed how deeply pharmaceutical industry protection runs in Congress, even among those who claim to be industry critics. This dynamic is particularly devastating for Black Americans, who face disproportionate rates of chronic disease and often become trapped in cycles of expensive pharmaceutical dependence, with little recourse when medications cause harm. The fact that a leading progressive senator worked to shield drug companies from legal accountability rather than ensure they face the consequences for potential wrongdoing speaks volumes about why our healthcare system remains broken, especially for the most vulnerable communities.

Robert F. Kennedy Jr.’s comparison of American and European food standards—highlighting that U.S. foods contain 10,000 chemical additives compared to Europe’s 400—was met with dismissal rather than alarm despite its disproportionate impact on Black communities. Due to food apartheid, many Black families rely on ultra-processed foods filled with artificial dyes, preservatives, and endocrine-disrupting chemicals—many of which are banned in Europe—leading to alarming health disparities. Black children face higher rates of obesity (24% vs. 16% in White children), type 2 diabetes (twice as likely), and asthma (15%, the highest of any racial group), while food dyes like Red 40 and Yellow 5 have been linked to hyperactivity and attention disorders. Yet, the U.S. continues to allow these harmful additives, prioritizing corporate profit over public health. With studies also linking chemical-laden diets to early puberty, metabolic disorders, and cognitive impairments, addressing this crisis requires systemic change—stricter regulations, equitable food policies, and access to clean, nutritious food for all communities, not just the privileged few.

The hearing’s most revealing moments came when Kennedy emphasized the need for prevention through better nutrition and environmental protection. Rather than engaging with these critical issues, senators repeatedly redirected the discussion to defending pharmaceutical interventions and the current healthcare system—a system that continues to fail Americans. The U.S. spends more on healthcare than any other nation yet achieves some of the worst health outcomes, particularly for marginalized communities.

Kennedy presented a stark critique of America’s healthcare system, particularly how it fails low-income populations. He pointed out that while Medicaid costs have increased by 60% over four years, access and quality of care for the poorest Americans—the program’s original focus—have actually declined. Many Medicaid recipients struggle with high premiums, high deductibles, and narrow provider networks, where top doctors and hospitals refuse to accept them. Kennedy likened the ongoing cost-shifting between the government, corporations, insurers, and families to “rearranging deck chairs on the Titanic,” as healthcare spending reaches 20% of GDP. He stressed that 90% of healthcare spending is directed toward managing chronic diseases, which disproportionately affect lower-income Americans, particularly Black communities. Without addressing the root causes—such as poor nutrition, environmental toxins, and lack of preventive care—the system remains unsustainable, leaving the most vulnerable populations trapped in a cycle of declining health despite skyrocketing spending. In his view, the expansion of Medicaid, while well-intentioned, has paradoxically resulted in poorer Americans being “robbed” of quality healthcare despite massive increases in spending.

Perhaps most disturbing was the resistance to Kennedy’s calls for “gold standard science” and transparency in health research. When he cited documented cases of research fraud and conflicts of interest within health agencies, senators seemed more concerned about maintaining institutional authority than addressing these legitimate concerns.

The exchange between Senator Raphael Warnock of Georgia and Kennedy revealed a telling moment about institutional resistance to reform. When questioned about his criticism of the CDC, Kennedy cited a 2003 Congressional oversight investigation that found the agency’s immunization safety office had “put institutional self-interests and pharmaceutical profits ahead of the welfare and health of American children.” Rather than addressing this documented finding, Senator Warnock dismissed it and continued pressing Kennedy about his rhetoric, sidestepping clear evidence of systemic issues within the agency he was defending. This moment exemplified how elected officials often prioritize protecting institutions over acknowledging their documented failures. That Warnock, who represents Georgia—the very state where the CDC is headquartered—ignored a Congressional report exposing serious flaws within the agency highlights how deeply entrenched resistance to reform has become, even when presented with official government findings.

This reluctance to confront systemic issues is especially troubling given the severe health disparities in Georgia, where Black residents face disproportionately high rates of chronic illness and poor health outcomes. In Georgia, hypertension affects 42% of Black adults, compared to 31% of White adults, and Black Georgians are twice as likely to die from diabetes-related complications. The state also has one of the highest maternal mortality rates in the nation, with Black women nearly three times more likely to die from pregnancy-related causes than White women. Additionally, heart disease and stroke account for nearly 40% of deaths among Black adults in Georgia, exacerbated by limited access to quality healthcare and preventive services. Rather than addressing these urgent issues, the exchange between Warnock and Kennedy reflected a broader pattern in American politics—where defending institutional authority takes precedence over holding agencies accountable for failures that disproportionately harm marginalized communities. This refusal to confront reality helps explain why America’s healthcare system remains broken despite overwhelming evidence of its flaws.

For Black Americans, who have historically suffered the most under the U.S. healthcare system, the senators’ defensive posturing was particularly troubling. Black communities face disproportionately high rates of diabetes (13% vs. 8% in White Americans), heart disease (more than 60% higher mortality rate than White Americans), obesity (49% vs. 42% in White Americans), and hypertension (56% vs. 48% in White Americans)—largely due to systemic factors such as food apartheid, limited healthcare access, and environmental racism. Yet, rather than address these root causes, the hearing focused on preserving the systems that perpetuate these disparities. Instead of implementing policies that promote equitable healthcare, nutrition access, and preventive care, lawmakers prioritized industry interests over the health of Black Americans, further entrenching the cycles of poor health outcomes and medical neglect.

The message was clear: challenging the profitable status quo – even with documented evidence of its failures – is considered more problematic than the devastating health outcomes it produces. This political theater plays out while Black Americans continue to face shorter lifespans, higher chronic disease rates, and poorer health outcomes.

Kennedy’s emphasis on prevention, environmental health, and holding pharmaceutical companies accountable represents a direct challenge to a system that profits from illness rather than wellness. The hostile reception to these ideas suggests many of our elected officials prefer managing disease to preventing it – a preference that continues to have deadly consequences, particularly in Black communities.

As chronic disease rates continue to soar and Black Americans continue to bear the heaviest burden of our failed health policies, the hearing demonstrated why real change seems so elusive: those in power appear more interested in protecting industry interests than pursuing genuine health solutions.

As a holistic practitioner, I’ve seen how addressing root causes—what we eat, lack of exercise, environmental toxins, and food quality—can transform health outcomes. Kennedy’s approach suggests he would bring this broader perspective to national health policy, potentially transforming a system that has particularly failed Black Americans and other marginalized communities.

The Senate’s decision isn’t just about a single nominee, despite how politics and the media may frame it. It isn’t about Trump, Democrats or Republicans. It’s about whether we are willing to take a broader, more comprehensive approach to America’s health crisis—one that considers all factors affecting human well-being, from nutrition and environmental exposure to healthcare access and systemic inequalities. This moment could be a crucial turning point toward meaningful, systemic change for communities that have long suffered under the current system.

Whether Kennedy wins confirmation or not, his hearing has elevated a crucial dialogue about the need for a more holistic approach to public health. For those of us who understand health through this broader lens, particularly in communities most impacted by our current system’s failures, this represents a significant moment in the fight for true health equity.